Treatment Approaches for COVID-19: A Critical Review
- 23 September 2021
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Mini-Reviews in Medicinal Chemistry
- Vol. 21 (13), 1747-1769
- https://doi.org/10.2174/1389557521666210224161950
Abstract
Background: Coronavirus disease 2019 (COVID-19) outbreak was declared as an emergency global public health concern on 30 January 2020. This novel coronavirus (SARS-CoV-2) outbreak was first identified in Wuhan city, China; which soon affected around 185 countries and territories all over the world through various transmission mechanisms. Having found no permanent cure to date, this pandemic threatens humanity for its very existence. Objective: In the light of rising menace, this review aims at providing collective and prominent information on the current outbreak covering its origin, structure, transmission, clinical features, potential treatment approaches, and clinical trial details. Method: Literature published in Scopus and PubMed indexed journals were reviewed and clinical trial data was retrieved from the ClinicalTrials.gov database. Results: Present review puts forth detailed insights on history, epidemiology, structure, genetic makeup, reservoirs, entry mechanisms, reproduction capacity, pathogenesis, routes of transmission, clinical features, diagnostics, the role of chloroquine in treatment, current promising therapies, and vaccination trials. Conclusion: At present, early detection, isolation of infected patients, and supportive care with a few recently USFDA approved alternative medications are being used as per the standard government guidelines. Due to insufficient proof available regarding current therapies to produce therapeutic activity against COVID-19, safety precautions, prevention methods, maintaining hygiene and management therapy with intensive care medicine is the only way to fight this current situation.Keywords
This publication has 119 references indexed in Scilit:
- Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4Cell Research, 2013
- Genomic Characterization of a Newly Discovered Coronavirus Associated with Acute Respiratory Distress Syndrome in HumansmBio, 2012
- Evidence Supporting a Zoonotic Origin of Human Coronavirus Strain NL63Journal of Virology, 2012
- Cleavage and Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein by Human Airway Trypsin-Like ProteaseJournal of Virology, 2011
- Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune ResponseJournal of Virology, 2011
- Mesenchymal stem cells for acute lung injury: Preclinical evidenceCritical Care Medicine, 2010
- Antiviral Activity of Chloroquine against Human Coronavirus OC43 Infection in Newborn MiceAntimicrobial Agents and Chemotherapy, 2009
- Coronaviruses post-SARS: update on replication and pathogenesisNature Reviews Microbiology, 2009
- Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sitesProceedings of the National Academy of Sciences of the United States of America, 2009
- Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injuryProceedings of the National Academy of Sciences of the United States of America, 2007